e14
Abstracts / Gynecologic Oncology 130 (2013) e1–e169
minimally invasive surgery and has several potential applications in gynecologic oncology surgery. doi:10.1016/j.ygyno.2013.04.090
Objective: This surgical film demonstrates techniques to perform a robotic total intracorporal pelvic exenteration with construction of an ileal conduit, end colostomy, and small bowel reanastomosis. Critical lessons learned are demonstrated. doi:10.1016/j.ygyno.2013.04.095
32 Robotic assisted modified posterior exenteration with total intracorporeal primary sigmoid rectal anastomosis P. Lim. Center of Hope at Renown Regional Medical Center, Reno, NV. Objective: To demonstrate a robotic surgical technique in performing an en bloc resection of uterus, fallopian tubes, ovaries, and pelvic and cul de sac peritoneum along with sigmoid resection for stage II ovarian cancer. doi:10.1016/j.ygyno.2013.04.091
33 Robotic splenectomy for ovarian cancer R. Holloway, J. James. Florida Hospital Cancer Institute, Orlando, FL. Objective: To describe a novel and safe technique for robotic-assisted laparoscopic splenectomy in a patient with recurrent ovarian cancer.
37 Identification of sacral plexus at robot-assisted nerve-sparing radical hysterectomy with extended lymphadenectomy Y. Lee, O. Chong, G. Hong. Kyungpook National University, Daegu, Republic of Korea. Objective: A robotic system has technical advantages over laparoscopic surgery because it increases the precision and accuracy of anatomic dissection, especially deep pelvic tissue. We used tge da Vinci system to demonstrate the surgical technique of identifying the sacral plexus as part of robot-assisted nerve-sparing radical hysterectomy with extended lymphadenectomy for early cervical cancer. Understanding the anatomy of the deep sacral plexus is necessary to prevent nerve injury in cases of extensive lymphadenectomy for high-risk cervical cancer. doi:10.1016/j.ygyno.2013.04.096
doi:10.1016/j.ygyno.2013.04.092
34 How to approach suspicious lymph nodes on the upper abdomen L. Chiva, A. Gonzalez-Martin, S. Alonso, F. Lapuente. MD Anderson International Spain, Madrid, Spain. Objective: To show some recommendations when dissection of lymph nodes above the renal vessels is indicated. The video contains surgical cases of patients with tumor-infiltrated lymph nodes in the following anatomic areas: suprarenal vessels, porta hepatis, celiac trunk, cisterna chyli, splenic hilum and pleuropericardial recess. It demonstrates the anatomic boundaries of these surgical locations as well as practical tips to improve skills when performing these procedures. doi:10.1016/j.ygyno.2013.04.093
35 Laparoendoscopic single-site radical hysterectomy for treatment of early cervical cancer D. Boruta, L. Bradford. Massachusetts General Hospital/Harvard University, Boston, MA. Objective: Performance of radical hysterectomy via laparoendoscopic single- site surgery (LESS) demonstrates the potential of LESS to be safely used for completion of even the most technically challenging of gynecologic surgical procedures. We hope to spur further interest in the development of this exciting approach within minimally invasive surgery. doi:10.1016/j.ygyno.2013.04.094
36 Robotic total intracorporal pelvic exenteration: Maximally invasive pelvic surgery performed in a minimally invasive fashion K. Levinson1, L. Weinberg2, M. Moslemi-Kebria2. 1Cleveland Clinic, Cleveland, OH, 2The Cleveland Clinic Foundation, Cleveland, OH.
38 Laparoscopic radical hysterectomy for bulky early-stage cervical cancer J. Nam, J. Park, D. Kim, J. Kim, Y. Kim, Y. Kim. University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. Objective: To present the surgical technique of laparoscopic radical hysterectomy in patients with bulky (N4 cm) early-stage cervical cancer (FIGO stage IB2 or IIA2). doi:10.1016/j.ygyno.2013.04.097
Scientific Plenary IV: Cancer Prevention and Beyond Sunday, March, 10, 2013, 4:30 p.m. -5:45 p.m. Concourse Hall (Los Angeles Convention Center) Moderators, Abstracts: 39-44: Joan Walker, MD, University of Oklahoma, Oklahoma City. Jeffrey Hines, MD, Southeastern Gynecologic Oncology at St. Joseph’s Hospital - Emory Healthcare, Atlanta, GA 39 Rural-urban disparity in declining ovarian cancer mortality rates: Analysis of US death records data from 1999 to 2009 A. Melamed1, J. Rauh-Hain2, R. Clark2, L. Bradford2, A. Goodman2, M. Del Carmen2, W. Growdon2, D. Boruta2, J. Schorge2. 1Massachusetts General Hospital/Brigham and Women’s Hospital, Boston, MA, 2Massachusetts General Hospital/Harvard University, Boston, MA. Objective: In the United States (US), ovarian cancer mortality rates have decreased among women of most racial and ethnic groups. Since access to centers specializing in ovarian cancer treatment is greater in urban centers, we hypothesized that the recent decline in ovarian cancer mortality has been more pronounced in highly urban areas then in more rural ones. Methods: The Multiple-Cause-of-Death database, which contains all US deaths from 1999-2009, was quarried using the Centers for Disease Control and Prevention’s internet-based WONDER interface. Ovarian